Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis

Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis

IntroductionWe performed a single-arm meta-analysis to evaluate the efficacy and safety of JAK inhibitors in the treatment of dermatomyositis (DM)/ polymyositis (PM).MethodsRelevant studies from four databases were systematically searched until April 25, 2023. The primary endpoint was Cutaneous Derm...

Full description

Bibliographic Details
Main Authors:	Chenhang Ma, Mengyao Liu, Yang Cheng, Xinchang Wang, Yu Zhao, Kailu Wang, Weijie Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Immunology
Subjects:	Janus kinase inhibitors idiopathic inflammatory myopathies polymyositis dermatomyositis interstitial lung disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1382728/full

Similar Items

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.
by: Agnieszka Trybuch, et al.
Published: (2023-07-01)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
by: Juyoung Yoo, et al.
Published: (2021-03-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
by: Miranda Houtman, et al.
Published: (2018-08-01)

POLYMYOSITIS/DERMATOMIOSITIS: DIFFERENTIAL DIAGNOSIS
by: O. A. Antelava
Published: (2016-07-01)

Study on advances in the association between autoantibodies and clinical phenotypes in idiopathic inflammatory myopathy
by: ZHANG Hao, CHI Huihui, SU Yutong, YANG Chengde
Published: (2022-06-01)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
by: Gilmara Franco da Cunha, et al.
Published: (2013-05-01)

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

MYOSITIS ASSOCIATED WITH MALIGNANT TUMORS
by: O. A. Antelava, et al.
Published: (2016-07-01)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
by: Marilda Guimarães Silva, et al.
Published: (2018-02-01)

Case of Polymyositis Associated with Celiac Disease: A Case Report
by: Abdul Rehman Azeem, et al.
Published: (2023-06-01)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

Polymyositis: clinical investigation in two sisters
by: Margô Gomes de Oliveira Karnikowski, et al.
Published: (2002-09-01)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
by: Takuya Hirai, et al.
Published: (2018-01-01)

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2014-05-01)

”Playing detective” in a case of paraneoplastic polymyositis
by: Elena Juganaru, et al.
Published: (2022-12-01)

PANNICULITIS IN DERMATOMYOSITIS
by: O. A. Antelava, et al.
Published: (2016-07-01)

The lungs were on fire: a pilot study of 18F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
by: Junyu Liang, et al.
Published: (2021-07-01)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
by: mei liu, et al.
Published: (2023-11-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Muscle biopsies in dermatomyositis and polymyositis: practical relevance of analyzing different levels of histological sections of the same muscular compartment
by: Monica T. M. Diaz, et al.
Published: (2017-06-01)

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach
by: Ha-Neul Jeong, et al.
Published: (2023-12-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies
by: Joanna E. Parkes, et al.
Published: (2020-06-01)

Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
by: Pengyan Qiao, et al.
Published: (2023-01-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
by: Kassem Sharif, et al.
Published: (2022-11-01)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
by: Tao Liu, et al.
Published: (2017-01-01)

18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes
by: Hanae Arai-Okuda, et al.
Published: (2020-08-01)

Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
by: Zoltan Griger, et al.
Published: (2020-09-01)

A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science
by: Xiao‐Na Ma, et al.
Published: (2024-02-01)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
by: Oksana Boyarchuk, et al.
Published: (2022-08-01)

Remarkable benefits of intravenous immunoglobulin (IVIG) in a patient with polymyositis-associated acute interstitial lung disease
by: Soran Peshbahar, et al.
Published: (2020-01-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis
by: Shih-Han Hung, et al.
Published: (2024-03-01)

Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study
by: Lao M, et al.
Published: (2023-01-01)

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
by: Nowak M, et al.
Published: (2016-06-01)

Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
by: Abdullah Mobeireek, et al.
Published: (2021-01-01)